nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—Peptide GPCRs—GNRHR—adrenal gland cancer	0.151	0.151	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—GNRHR—adrenal gland cancer	0.128	0.128	CbGpPWpGaD
Maraviroc—CCR5—Peptide GPCRs—TSHR—adrenal gland cancer	0.0809	0.0809	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0478	0.0478	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—CDC42—adrenal gland cancer	0.0421	0.0421	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0364	0.0364	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0286	0.0286	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0255	0.0255	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0218	0.0218	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0206	0.0206	CbGpPWpGaD
Maraviroc—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0204	0.0204	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—TSHR—adrenal gland cancer	0.0194	0.0194	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0187	0.0187	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0187	0.0187	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.0149	0.0149	CbGpPWpGaD
Maraviroc—CCR5—Disease—SH3KBP1—adrenal gland cancer	0.0146	0.0146	CbGpPWpGaD
Maraviroc—CCR5—Disease—ZNRF3—adrenal gland cancer	0.0138	0.0138	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—POMC—adrenal gland cancer	0.0126	0.0126	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0123	0.0123	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—GNAS—adrenal gland cancer	0.0113	0.0113	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0112	0.0112	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.0112	0.0112	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GNRHR—adrenal gland cancer	0.011	0.011	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.011	0.011	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0103	0.0103	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00999	0.00999	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00997	0.00997	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00964	0.00964	CbGpPWpGaD
Maraviroc—CCR5—Disease—SPRY2—adrenal gland cancer	0.00863	0.00863	CbGpPWpGaD
Maraviroc—CCR5—Disease—MEN1—adrenal gland cancer	0.00791	0.00791	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—POMC—adrenal gland cancer	0.00761	0.00761	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00716	0.00716	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00673	0.00673	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00669	0.00669	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00661	0.00661	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00641	0.00641	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00639	0.00639	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00607	0.00607	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00605	0.00605	CbGpPWpGaD
Maraviroc—CCR5—Disease—PRKACA—adrenal gland cancer	0.00604	0.00604	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TSHR—adrenal gland cancer	0.00589	0.00589	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GNAS—adrenal gland cancer	0.0058	0.0058	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MEN1—adrenal gland cancer	0.00554	0.00554	CbGpPWpGaD
Maraviroc—CCR5—Disease—CDC42—adrenal gland cancer	0.00512	0.00512	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—POMC—adrenal gland cancer	0.0043	0.0043	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKACA—adrenal gland cancer	0.00423	0.00423	CbGpPWpGaD
Maraviroc—CCR5—Disease—TERT—adrenal gland cancer	0.00411	0.00411	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—POMC—adrenal gland cancer	0.00391	0.00391	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CDC42—adrenal gland cancer	0.00359	0.00359	CbGpPWpGaD
Maraviroc—CCR5—Disease—BAD—adrenal gland cancer	0.00357	0.00357	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF2—adrenal gland cancer	0.00346	0.00346	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GNAS—adrenal gland cancer	0.00343	0.00343	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF1R—adrenal gland cancer	0.00334	0.00334	CbGpPWpGaD
Maraviroc—CCR5—Disease—BRAF—adrenal gland cancer	0.00325	0.00325	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TERT—adrenal gland cancer	0.00288	0.00288	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00279	0.00279	CbGpPWpGaD
Maraviroc—CCR5—Disease—PTGS2—adrenal gland cancer	0.00263	0.00263	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—BAD—adrenal gland cancer	0.0025	0.0025	CbGpPWpGaD
Maraviroc—CCR5—Disease—CTNNB1—adrenal gland cancer	0.00235	0.00235	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—POMC—adrenal gland cancer	0.00231	0.00231	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—BRAF—adrenal gland cancer	0.00228	0.00228	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00226	0.00226	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—EGFR—adrenal gland cancer	0.00221	0.00221	CbGpPWpGaD
Maraviroc—CCR5—Disease—EGFR—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EGFR—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TP53—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000693	0.000693	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000693	0.000693	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000517	0.000517	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000377	0.000377	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000305	0.000305	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.0003	0.0003	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000206	0.000206	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000164	0.000164	CbGpPWpGaD
